Rac1 activation in human breast carcinoma as a prognostic factor associated with therapeutic resistance.
Mio YamaguchiKiyoshi TakagiAi SatoYasuhiro MikiMinoru MiyashitaHironobu SasanoTakashi SuzukiPublished in: Breast cancer (Tokyo, Japan) (2020)
These findings suggested Rac1 activation played pivotal roles in the progression and therapeutic resistance of breast cancers and Rac1 might be an important therapeutic target for improvement of the therapy for breast cancer patients.